GC-MS combines two complementary measurements: chromatographic separation reduces the complexity of a mixture, while mass spectrometry provides a compound-specific ion pattern. After ionization, the instrument sorts ions by mass-to-charge ratio, generating a characteristic spectrum that supports identification and measurement of compounds present in the biological sample.
During the chromatographic stage, compounds do not move through the column identically. Their separation reflects interactions with the stationary phase and the carrier gas, so constituents of a complex sample reach the mass spectrometer at different times. This timing helps distinguish compounds whose signals might otherwise overlap in a biological mixture.
The two stages answer different analytical questions. Retention through the gas chromatograph provides separation based on column interactions, whereas the mass spectrum supplies an identifying pattern after ionization. Keeping these roles distinct helps interpret complex biological results: a separated signal can be associated with a compound’s characteristic spectrum rather than treated as an undifferentiated mixture response.
Suitability depends on whether the compound is volatile and thermally stable enough to pass through the gas chromatograph without being lost or altered during vaporization and separation. This constraint explains why the method is especially useful for selected small molecules, fatty acids, and other analytes that meet those physical requirements.
Analysis proceeds from sample vaporization to chromatographic separation, followed by ionization of each compound and sorting of the resulting ions by mass-to-charge ratio. The resulting spectra are then used to identify and measure compounds. In biology, this workflow turns a complex sample into chemical information that can be related to physiology, disease, or exposure.
Metabolite profiling uses GC-MS to examine patterns of small molecules in complex biological samples rather than focusing on a single substance alone. Measurements can reveal differences in chemical composition that researchers then relate to physiological state or disease. The method therefore connects molecular observations with broader biological processes, provided the compounds are suitable for analysis.
It can detect and measure drugs or environmental chemicals in biological tissues and fluids, allowing chemical exposure to be examined alongside biological context. These applications extend beyond routine compound identification: the measured presence of such substances can help researchers study how external chemicals relate to physiology, disease, or exposure-related questions.